Cornerstone Capital Management Holdings’s Vertex Pharmaceuticals VRTX Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$7.12M	Buy	47,549 +4,244	+10%	+$628K	0.05%	365
2017 Q3	$6.58M	Buy	43,305 +471	+1%	+$70.9K	0.05%	366
2017 Q2	$5.52M	Sell	42,834 -132	-0.3%	-$15.9K	0.04%	409
2017 Q1	$4.7M	Sell	42,966 -145	-0.3%	-$12.8K	0.04%	479
2016 Q4	$3.17M	Sell	43,111 -3,554	-8%	-$289K	0.02%	610
2016 Q3	$4.07M	Sell	46,665 -6,713	-13%	-$634K	0.03%	529
2016 Q2	$4.59M	Buy	53,378 +727	+1%	+$62.8K	0.04%	472
2016 Q1	$4.18M	Sell	52,651 -1,109	-2%	-$100K	0.03%	511
2015 Q4	$6.76M	Sell	53,760 -912	-2%	-$110K	0.06%	370
2015 Q3	$5.69M	Sell	54,672 -30,824	-36%	-$3.96M	0.05%	388
2015 Q2	$10.6M	Sell	85,496 -71,618	-46%	-$9.02M	0.09%	251
2015 Q1	$18.5M	Buy	157,114 +41,477	+36%	+$4.97M	0.17%	143
2014 Q4	$13.7M	Buy	115,637 +62,268	+117%	+$7.01M	0.14%	195
2014 Q3	$5.99M	Buy	53,369 +367	+0.7%	+$34.9K	0.07%	372
2014 Q2	$5.02M	Sell	53,002 -144	-0.3%	-$10.1K	0.06%	422
2014 Q1	$3.76M	Sell	53,146 -12,331	-19%	-$977K	0.04%	453
2013 Q4	$4.86M	Sell	65,477 -92,891	-59%	-$6.47M	0.06%	407
2013 Q3	$12M	Buy	158,368 +137,054	+643%	+$10.9M	0.14%	182
2013 Q2	$1.71M	Buy	+21,314	New	+$1.57M	0.02%	686

Other funds holding VRTX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Cornerstone Capital Management Holdings's VRTX Position: Q4 2017 in Review

Cornerstone Capital Management Holdings increased its Vertex Pharmaceuticals (VRTX) stake by 9.8% in Q4 2017, buying an estimated $628K and bringing the position to 47,549 shares worth $7.12M. The position accounts for 0.05% of the portfolio, ranked #365.

Cornerstone Capital Management Holdings first reported a position in VRTX in Q2 2013 and has held it in 19 quarters since. The position peaked at $18.5M in Q1 2015. 644 funds tracked by Wall St. Rank hold VRTX as of Q4 2017.

Cornerstone Capital Management Holdings held 47,549 shares of Vertex Pharmaceuticals worth $7.12M as of Q4 2017.
Cornerstone Capital Management Holdings bought 4,244 Vertex Pharmaceuticals shares in Q4 2017, an estimated $628K.
Vertex Pharmaceuticals made up 0.05% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #365 holding.
Cornerstone Capital Management Holdings first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 19 quarters since.
Cornerstone Capital Management Holdings's Vertex Pharmaceuticals position peaked at $18.5M in Q1 2015.
644 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.